Intrinsic Value of S&P & Nasdaq Contact Us

Fate Therapeutics, Inc. FATE

NASDAQ Global Market

SharesGrow Score
46/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$39.50
+2847.8%

Fate Therapeutics, Inc. (FATE) current share price is $1.34. The gold spot price is $4,808.10 per troy ounce. Using the formula: FATE in gold = $1.34 × 31.1035 ÷ $4,808.10 = 0.0087 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of FATE when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding FATE shares over the measured period.

FATE in US Dollars
Gold in US Dollars
FATE in Gold (grams per share)

Real Wealth Growth Rate

FATE
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{FATE}_{\text{gold}}(t) = \frac{P_{\text{FATE}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{FATE}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{FATE}_{\text{gold}}^{(T)}}{\text{FATE}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{FATE}_\text{gold}^{(0)}$ = initial gold-price, $\text{FATE}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

BPMC
BPMC
Blueprint Medicines Corporation
$129.46
+0.14%
CRSP
CRSP
CRISPR Therapeutics AG
$56.86
+3.70%
BEAM
BEAM
Beam Therapeutics Inc.
$30.30
+0.40%
RLAY
RLAY
Relay Therapeutics, Inc.
$14.75
-3.34%
RCUS
RCUS
Arcus Biosciences, Inc.
$23.01
+2.77%
NTLA
NTLA
Intellia Therapeutics, Inc.
$14.78
+3.65%
VERV
VERV
Verve Therapeutics, Inc.
$11.13
+0.27%
SANA
SANA
Sana Biotechnology, Inc.
$3.48
+8.41%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message